AAAAAA

   
Results: 1-8 |
Results: 8
MULTICENTER PROSPECTIVE RANDOMIZED TRIAL OF FLUDARABINE VERSUS CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (CAP) FOR TREATMENT OF ADVANCED-STAGE CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: FENAUX P BINET JL LEPORRIER M TRAVADE P PIGUET H LINASSIER C DESABLENS B DREYFUS B BRIZARD CP MURGUE B RUSSET T SOUTEYRAND P JOHNSON S PHILLIPS MJ HIDDEMANN W SMITH A ROATH S LOFFLER H BJORKHOLM M OSBY E EMMERICH B COIFFIER B THIEL E KNAUF W JULIUSSON G MARCUS R PRENTICE AG COPPLESTONE JA FREUND M MILLIGAN PW WINFIELD D YIN J HELLRIEGEL KP HOSSFELD DK KIMBY E BURNETT AK LISTER TA LUCIE N KANZ L LERNER R LINDEMALM C CHILD A HAMBLIN T OSCIER D SMITH JG SINGER RJ PARKER A WHITTAKER J WYLD P SMITH AG
Citation: P. Fenaux et al., MULTICENTER PROSPECTIVE RANDOMIZED TRIAL OF FLUDARABINE VERSUS CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (CAP) FOR TREATMENT OF ADVANCED-STAGE CHRONIC LYMPHOCYTIC-LEUKEMIA, Lancet, 347(9013), 1996, pp. 1432-1438
TREATMENT OF THE ANEMIA IN MDS WITH G-CSF AND EPO - FINAL REPORT FROMA RANDOMIZED PHASE-II STUDY
Authors: HELLSTROMLINDBERG E TANGEN JM GRIMFORS G LINDEMALM C CARLSSON M OBERG G LOWENBERG E LINDER O DYBEDAL I DAHL IM NILSSONEHLE H AHLGREN T WINQUIST I CARNESKOG J LUTHMAN M
Citation: E. Hellstromlindberg et al., TREATMENT OF THE ANEMIA IN MDS WITH G-CSF AND EPO - FINAL REPORT FROMA RANDOMIZED PHASE-II STUDY, Blood, 88(10), 1996, pp. 1805-1805
DIFFERENT DOSE REGIMENS OF THE MOUSE MONOCLONAL-ANTIBODY 17-1A FOR THERAPY OF PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA
Authors: RAGNHAMMAR P FRODIN JE HJELM AL FAGERBERG J WERSALL P LINDEMALM C NILSSON B FOX K MAGNUSSON I EWERTH S THOR K SECHER E MELLSTEDT H
Citation: P. Ragnhammar et al., DIFFERENT DOSE REGIMENS OF THE MOUSE MONOCLONAL-ANTIBODY 17-1A FOR THERAPY OF PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA, International journal of oncology, 7(5), 1995, pp. 1049-1056
CHLORAMBUCIL PREDNISONE VS CHOP IN SYMPTOMATIC LOW-GRADE NON-HODGKINS-LYMPHOMAS - A RANDOMIZED TRIAL FROM THE LYMPHOMA-GROUP-OF-CENTRAL-SWEDEN
Authors: KIMBY E BJORKHOLM M GAHRTON G GLIMELIUS B HAGBERG H JOHANSSON B JOHANSSON H JULIUSSON G JARNMARK M LOFVENBERG E KILLANDER A LERNER R LINDEMALM C PETTERSSON U ROBERT KH SIMONSSON B STALFELT AM SUNDSTROM C SVEDMYR E UDEN AM WADMAN B WAHLIN A OST A MELLSTEDT H
Citation: E. Kimby et al., CHLORAMBUCIL PREDNISONE VS CHOP IN SYMPTOMATIC LOW-GRADE NON-HODGKINS-LYMPHOMAS - A RANDOMIZED TRIAL FROM THE LYMPHOMA-GROUP-OF-CENTRAL-SWEDEN, Annals of oncology, 5, 1994, pp. 190000067-190000071
SYNERGISTIC EFFECT OF G-CSF AND EPO ON THE ANEMIA IN PATIENTS WITH MDS - EVIDENCE FOR INCREASED ERYTHROPOIETIC EFFECTIVENESS RATHER THAN EXPANSION
Authors: HELLSTROMLINDBERG E CARLSSON M CARNESKOG J DAHL IM DYBEDAL I GRIMFORS G LINDEMALM C LINDER O LOFVENBERG E NILSSONEHLE H TANGEN JM TURESSON I WINQVIST I OBERG G BEGIN Y OST A
Citation: E. Hellstromlindberg et al., SYNERGISTIC EFFECT OF G-CSF AND EPO ON THE ANEMIA IN PATIENTS WITH MDS - EVIDENCE FOR INCREASED ERYTHROPOIETIC EFFECTIVENESS RATHER THAN EXPANSION, Blood, 84(10), 1994, pp. 10000317-10000317
ALPHA-INTERFERON (WELLFERON), CYCLOPHOSPHAMIDE AND HIGH-DOSE BETAMETHASONE (CIB) FOLLOWED BY GM-CSF FOR TREATMENT OF MULTIPLE-MYELOMA - A PILOT-STUDY
Authors: OSTERBORG A BJORKHOLM M BJOREMAN M BRENNING G CARLSON K CELSING F GAHRTON G GRIMFORS G GYLLENHAMMAR H HAST R JOHANSSON B JULIUSSON G JARNMARK M KIMBY E LERNER R LINDEMALM C LINDER O OHRLING M PAUL C SIMONSSON B SKARBERG KF SMEDMYR B STRANDER H SVEDMYR E TIDEFELT U UDEN AM WERNER B OSBY E MELLSTEDT H
Citation: A. Osterborg et al., ALPHA-INTERFERON (WELLFERON), CYCLOPHOSPHAMIDE AND HIGH-DOSE BETAMETHASONE (CIB) FOLLOWED BY GM-CSF FOR TREATMENT OF MULTIPLE-MYELOMA - A PILOT-STUDY, Blood, 84(10), 1994, pp. 10000657-10000657
LOW-DOSE CYCLOPHOSPHAMIDE, ALPHA-INTERFERON AND CONTINUOUS INFUSIONS OF INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA
Authors: WERSALL JP MASUCCI G HJELM AL RAGNHAMMAR P FAGERBERG J FRODIN JE MERK K LINDEMALM C ERICSON K KALIN B MELLSTEDT H
Citation: Jp. Wersall et al., LOW-DOSE CYCLOPHOSPHAMIDE, ALPHA-INTERFERON AND CONTINUOUS INFUSIONS OF INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA, Medical oncology and tumor pharmacotherapy, 10(3), 1993, pp. 103-111
THE COMBINATION OF GRANULOCYTE-CSF AND ERYTHROPOIETIN (EPO) MAY SIGNIFICANTLY INCREASE THE HEMOGLOBIN LEVELS IN MDS-PATIENTS WITH NO RESPONSE TO EPO ALONE - REPORT FROM A RANDOMIZED PHASE-II TRIAL
Authors: HELLSTROMLINDBERG E CARLSSON M GRIMFORS G LINDEMALM C LOFVENBERG E TANGEN JM OST A
Citation: E. Hellstromlindberg et al., THE COMBINATION OF GRANULOCYTE-CSF AND ERYTHROPOIETIN (EPO) MAY SIGNIFICANTLY INCREASE THE HEMOGLOBIN LEVELS IN MDS-PATIENTS WITH NO RESPONSE TO EPO ALONE - REPORT FROM A RANDOMIZED PHASE-II TRIAL, Blood, 82(10), 1993, pp. 10000376-10000376
Risultati: 1-8 |